Literature DB >> 19918332

Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction?

Rosemary A Recavarren1, Mamatha Chivukula, Gloria Carter, David J Dabbs.   

Abstract

The significance of association between cancer and its microenvironment has been increasingly recognized. It has been shown in animal models that interaction between neoplastic epithelial cells and adjacent stroma can modulate tumor behavior. Carcinoma associated stromal cells can transform normal epithelial cells into neoplastic cells. In breast, columnar cell lesions are non-obligate precursors of low grade ductal carcinoma in situ. Columnar cell lesions can be seen intimately associated with PASH-like-stroma, a lesion we termed as CCPLS. Our aim is to investigate epithelial-stromal interactions in CCPLS and compare them to PASH without columnar cell lesions in breast core needle biopsies. Normal terminal duct lobular unit (TDLU) epithelium was seen in association with columnar cell lesions as well as PASH. Eight (8) cases of each category were examined by a panel of immunostains: CD117 (C-kit), CD34, CD105, bFGF, AR, ER-beta, MIB-1. We observed a markedly decreased expression of c-kit in columnar cell lesions compared to TDLU-epithelium. CD105 showed a quantitative increase in activated vessels in CCPLS compared to PASH. A subset of CCPLS and PASH were androgen receptor positive. A strong nuclear positivity for ER-beta is observed in the epithelium and stroma of all CCPLS cases. We conclude that (1) activated blood vessels predominate in CCPLS; (2) A molecular alteration is signified by c-kit loss in columnar cell lesions; (3) ER-beta and androgen receptor positivity indicate CCPLS are hormonally responsive lesions. Our study suggests an intimate vascular and hormone dependent epithelial-stromal interaction exists in CCPLS lesions.

Entities:  

Keywords:  AR; Columnar cell; ER-beta; c-kit; pseudoangiomatous stromal hyperplasia

Mesh:

Substances:

Year:  2009        PMID: 19918332      PMCID: PMC2776264     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

Review 1.  Columnar cell lesions of the breast.

Authors:  Stuart J Schnitt; Anne Vincent-Salomon
Journal:  Adv Anat Pathol       Date:  2003-05       Impact factor: 3.875

2.  Reconstruction of functionally normal and malignant human breast tissues in mice.

Authors:  Charlotte Kuperwasser; Tony Chavarria; Min Wu; Greg Magrane; Joe W Gray; Loucinda Carey; Andrea Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

3.  Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.

Authors:  T Moore; A H Lee
Journal:  Histopathology       Date:  2001-01       Impact factor: 5.087

4.  Molecular alterations in columnar cell lesions of the breast.

Authors:  David J Dabbs; Gloria Carter; Mary Fudge; Yan Peng; Pat Swalsky; Sidney Finkelstein
Journal:  Mod Pathol       Date:  2006-03       Impact factor: 7.842

5.  Pseudoangiomatous stromal hyperplasia of the breast.

Authors:  Claudia Y Castro; Gary J Whitman; Aysegul A Sahin
Journal:  Am J Clin Oncol       Date:  2002-04       Impact factor: 2.339

6.  A mouse model of human breast cancer metastasis to human bone.

Authors:  Charlotte Kuperwasser; Scott Dessain; Benjamin E Bierbaum; Dan Garnet; Kara Sperandio; Gregory P Gauvin; Stephen P Naber; Robert A Weinberg; Michael Rosenblatt
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

7.  Malignant neoplasms infiltrating pseudoangiomatous' stromal hyperplasia of the breast: an unrecognized pathway of tumour spread.

Authors:  S Damiani; V Eusebi; J L Peterse
Journal:  Histopathology       Date:  2002-09       Impact factor: 5.087

Review 8.  CD105 is important for angiogenesis: evidence and potential applications.

Authors:  Sarah E Duff; Chenggang Li; John M Garland; Shant Kumar
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

9.  Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.

Authors:  Jean-Philippe Dales; Stephane Garcia; Lucile Andrac; Severine Carpentier; Olivier Ramuz; Marie-Noëlle Lavaut; Claude Allasia; Pascal Bonnier; Colette Charpin
Journal:  Int J Oncol       Date:  2004-05       Impact factor: 5.650

Review 10.  The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer.

Authors:  A E Roussidis; A D Theocharis; G N Tzanakakis; N K Karamanos
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more
  2 in total

1.  Inflammatory Myofibroblastic Tumor of the Breast Coexisting with Pseudoangiomatous Stromal Hyperplasia.

Authors:  Canan Kelten Talu; Yasemin Çakır; Ezgi Hacıhasanoğlu; Cem Leblebici; Şefika Aksoy; Mehmet Ali Nazlı
Journal:  J Breast Health       Date:  2016-10-01

2.  Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.

Authors:  Sofie Björner; Paul A Fitzpatrick; Yaoyong Li; Craig Allred; Anthony Howell; Anita Ringberg; Håkan Olsson; Crispin J Miller; Håkan Axelson; Göran Landberg
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.